Zamboni is expected to say the ‘Tanner study — which was not submitted to the FDA until 2019 — provides evidence that GSK ...
UK pharmaceutical giant GSK says it will pay as much as $2.2bn (£1.68bn) to settle thousands of cases in US courts over ...
Shares in GSK fell around 9% this morning after ... of lawsuits claiming harm by gastrointestinal drug Zantac to proceed to trial. Judge Vivian Medinilla of Delaware Superior Court issued an ...
GSK plc (LSE/NYSE: GSK), a leading global pharmaceutical company, has reached a confidential settlement in a Zantac (ranitidine ... SWIFT-2 phase III clinical trials. However, the company ...
"They say in the trial, 'All you need to know is the science and we win,' and that argument ... which will be the first Zantac trials in California." GlaxoSmithKline didn't admit liability ...
(Reuters) - British drugmaker GSK said on Wednesday it had agreed to settle two lawsuits in California that claimed its discontinued heartburn drug Zantac caused cancer. GSK does not admit to ...
The case, brought by Illinois resident Ronald Kimbrow, alleged that Zantac caused his prostate cancer after he took the drug from 1995 to 2019. The sole defendant in the trial was German drugmaker ...
Feedback